Program ACTIVE II: A Comparative Effectiveness Trial to Treat Major Depression in T2DM

被引：0
|
作者：
De Groot, Mary
Hornsby, Guy
Saha, Chandan
Yang, Ziyi
Pillay, Yegan
Fitzpatrick, Karen
Mather, Kieren J.
Shubrook, Jay
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
376-OR
引用
收藏
页码：A99 / A99
页数：1
相关论文
共 50 条
  • [21] FEASibility testing a randomized controlled trial of an exercise program to improve cognition for T2DM patients (the FEAST trial): A study protocol
    Liu, Tingting
    Hettish, Lindsey
    Lo, Wen-Juo
    Gray, Michelle
    Li, Changwei
    RESEARCH IN NURSING & HEALTH, 2021, 44 (05) : 746 - 757
  • [22] Implications of ACCORD Trial Are Unclear to Clinicians Managing Patients With T2DM
    Tamas, Margery J.
    Mcintosh, Angela C.
    Carbonara, Amarynthia
    Weinman, Steven A.
    DIABETES, 2013, 62 : A179 - A179
  • [23] The Effectiveness of an eHealth Family-Based Intervention Program in Patients With Uncontrolled Type 2 Diabetes Mellitus (T2DM) in the Community Via WeChat: Randomized Controlled Trial
    Feng, Yuheng
    Zhao, Yuxi
    Mao, Linqi
    Gu, Minmin
    Yuan, Hong
    Lu, Jun
    Zhang, Qi
    Zhao, Qian
    Li, Xiaohong
    JMIR MHEALTH AND UHEALTH, 2023, 11 (01):
  • [24] Efficacy and Safety of Sitagliptin in Subjects with T2DM and Depression Using Antidepressant Medications
    Makimura, Hideo
    Pong, Annpey
    Kaufman, Keith D.
    O'Neill, Edward A.
    Engel, Samuel S.
    DIABETES, 2017, 66 : A351 - A351
  • [25] COST EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH T2DM AND HIGH CV RISK IN CANADA
    Mettam, S. R.
    Bajaj, H.
    Kansal, A. R.
    Kandaswamy, P.
    VALUE IN HEALTH, 2016, 19 (07) : A674 - A674
  • [26] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    DIABETES, 2019, 68
  • [27] Effectiveness of Vildagliptin 100 mg SR OD in T2DM Patients with Hypertension
    Warrier, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [28] COST-EFFECTIVENESS CONSEQUENCES OF OBESITY IN T2DM BY INSULIN ANALOGUE THERAPY
    Jozsa, Z.
    Toth, E.
    Nagy, B.
    VALUE IN HEALTH, 2010, 13 (07) : A289 - A289
  • [29] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Thulasi, Arun
    Kumar, Vinod
    Jagannathan, Aarti
    Angadi, Praveen
    Umamaheswar, Kundapur
    Raghuram, Nagarathna
    JOURNAL OF RELIGION & HEALTH, 2022, 61 (03): : 1951 - 1965
  • [30] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Arun Thulasi
    Vinod Kumar
    Aarti Jagannathan
    Praveen Angadi
    Kundapur Umamaheswar
    Nagarathna Raghuram
    Journal of Religion and Health, 2022, 61 : 1951 - 1965
12345